Publications by authors named "Hossam Elsayed"
Osteochondral lesions of the talus are chondral lesions affecting the subchondral bone mostly due to acute ankle trauma, including either sprains or fractures. After failure of conservative treatment, operative treatment is necessary, with different surgical techniques described in the literature. We describe a single-step osteochondral autograft transfer to access the medial talar dome lesion that avoids the need for a medial malleolar osteotomy and therefore eliminates morbidity while reducing operative time.
View Article and Find Full Text PDFObjective: Revision to cardiac resynchronisation therapy (CRT) in patients with existing pacemakers with worsening heart failure (HF) can improve symptoms and cardiac function. We identify factors that predict improvement in left ventricular ejection fraction (LVEF) within a year of CRT revision.
Methods: We performed a retrospective study of 146 consecutive patients (16% female, mean age 73 ± 11 years, mean LVEF 27 ± 8%) undergoing revision to CRT (January 2012 to May 2018) in a single tertiary centre.
Article Synopsis
- Temporary cardiac pacing using externalized prolonged temporary pacing (EPTP) can be a safe alternative to traditional methods, especially for patients who can't have permanent pacemakers due to conditions like sepsis.
- In a study of 67 patients averaging 69 years old, EPTP was usually used for serious heart rhythm issues and was effective, with a mean pacing duration of 16 days.
- The results showed good outcomes, with 63% of patients receiving permanent devices afterward and no significant complications related to EPTP, indicating its usefulness in critical care scenarios.
Article Synopsis
- Sacubitril/valsartan has shown effectiveness in treating heart failure with reduced ejection fraction (HFrEF) in clinical trials, but its real-world impact was previously unclear.* -
- In a study involving 80 patients who were switched to sacubitril/valsartan, significant improvements were observed in blood pressure, heart function scores, and echocardiographic measurements after three months.* -
- The findings suggest that switching to sacubitril/valsartan can lead to better functional outcomes in HFrEF patients already receiving optimal treatment, highlighting its potential benefits in everyday clinical practice.*